<DOC>
	<DOC>NCT01809574</DOC>
	<brief_summary>We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.</brief_summary>
	<brief_title>The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Lung Diseases, Interstitial</mesh_term>
	<mesh_term>Connective Tissue Diseases</mesh_term>
	<criteria>Age above 18 years old ILD according to ATS/ERS guidelines Signed inform consent Previous lung surgery Other significant systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Interstitial lung disease</keyword>
	<keyword>Idiopathic pulmonary fibrosis</keyword>
	<keyword>Connective tissue disease</keyword>
</DOC>